Drug-labels.com

Novo-Valsartan: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
40 mg, 80 mg, 160 mg, 320 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Novo-Valsartan

ABOUT THIS MEDICATION

What the medication is used for:

NOVO-VALSARTAN is used to lower blood pressure or to treat people after a heart attack (myocardial infarction) when the use of an angiotensin-converting enzyme (ACE) inhibitor, considered part of standard therapy for this condition, is not appropriate.

NOVO-VALSARTAN is also used in patients with chronic heart failure, when they are unable to tolerate the standard treatment with medications called ACE inhibitors. There is no evidence that NOVO-VALSARTAN provides added benefit when it is used with ACE inhibitors.

High blood pressure increases the workload of the heart and arteries. If this condition continues for a long time, damage to the blood vessels of the brain, heart, and kidneys can occur, and may eventually result in a stroke, heart failure or kidney failure. High blood pressure also increases the risk of heart attacks. Reducing your blood pressure decreases your risk of developing these illnesses.

What it does:

NOVO-VALSARTAN belongs to a class of medicines known as angiotensin II receptor blocker, which help to control high blood pressure or other heart-related problems. Angiotensin II is a natural hormone produced in the body to keep blood pressure at normal levels. One function of angiotensin II is to increase blood pressure, usually when it becomes too low. NOVO-VALSARTAN works by blocking the effect of angiotensin II. As a result, blood pressure is lowered.

When it should not be used:

You should not take NOVO-VALSARTAN if:

  • you have ever had an unusual or allergic reaction to

    valsartan or to any other component of this product,

  • you are pregnant or plan to become pregnant.

NOVO-VALSARTAN is not recommended for children and adolescents (below the age of 18 years).

What the medicinal ingredient is:

Valsartan

What the important nonmedicinal ingredients are: NOVO-VALSARTAN also contains the following non-medicinal ingredients: colloidal anhydrous silica, crospovidone, magnesium stearate, microcrystalline cellulose, sodium starch glycolate and starch. The coating contains: FD&C Blue #2 Aluminum Lake (320 mg), FD&C Yellow #6 Aluminum Lake (320 mg) hypromellose, polyethylene glycol, iron oxide red (80, 160 and 320 mg), talc, titanium dioxide, yellow iron oxide (40 mg and 160 mg)

What dosage forms it comes in:

NOVO-VALSARTAN is available in four tablet strengths containing valsartan 40 mg, 80 mg, 160 mg and 320 mg.

NOVO-VALSARTAN 40mg is a divisible film-coated tablet. The 20 mg dose may be obtained by dividing a 40 mg tablet in half at the break line.

  • NOVO-VALSARTAN tablets, 40 mg are yellow, oval shaped, film coated tablets, scored on one side and debossed with “N” and “40” on the other side.
  • NOVO-VALSARTAN tablets, 80 mg are pink, round shaped, film coated tablets, debossed with “N” on one side and “80” on the other side.
  • NOVO-VALSARTAN tablets, 160 mg are yellow, oval shaped, film coated tablets, debossed with “N” on one side and “160” on the other side.
  • NOVO-VALSARTAN tablets, 320 mg are purple, oval shaped, film coated tablets, debossed with “N” on one side and “320” on the other side.

WARNINGS AND PRECAUTIONS

Serious warnings and precautions

NOVO-VALSARTAN should not be used during pregnancy. If you discover that you are pregnant while taking NOVO-VALSARTAN, stop the medication and please contact your physician.

BEFORE you use NOVO-VALSARTAN talk to your doctor or pharmacist if:

  • you have a kidney or liver disease
  • you are being treated with diureticts
  • you are suffering from excess vomiting or diarrhea
  • you have any allergies to this drug or its ingredients or components of the container

You are pregnant, breast-feeding or thinking of becoming pregnant?

Taking NOVO-VALSARTAN during pregnancy can cause injury and even death to your baby. This medicine should not be used during pregnancy. If you are planning to become pregnant while taking NOVO-VALSARTAN, contact immediately your doctor.

It is possible that NOVO-VALSARTAN passes into breast milk. You should discuss with you doctor about taking NOVO-VALSARTAN while breastfeeding

Similar medicines were associated with serious harm to fetuses when they were taken after the first three months of pregnancy. (It is not known if they are harmful during the first three months). It is therefore important to tell your doctor immediately if you think you may have become pregnant, or planning to become pregnant. Your doctor will discuss with you the potential risk of taking

NOVO-VALSARTAN during pregnancy.

Although it is not known whether NOVO-VALSARTAN can pass into human breast milk, this does happen in animals. Therefore do not breast-feed during treatment. Tell your doctor if you are breast-feeding, so that other treatment options can be tried.

Like many other medicines used to treat high blood pressure, NOVO-VALSARTAN may rarely cause dizziness and affect your concentration. So before you drive a vehicle, use machinery, or do other things that need concentration, make sure you know how you react to the effects of NOVO-VALSARTAN.

INTERACTIONS WITH THIS MEDICATION

As with other medicines, interactions with other drugs are possible. Therefore, do not take any other medicines unless you have discussed the matter with your physician or your pharmacist.

Drugs that may interact with NOVO-VALSARTAN include:

  • medicines used to lower blood pressure, including diuretics

    (water pills),

  • potassium-sparing medicines, potassium supplements, or

    salt substitutes containing potassium,

  • lithium therapy

Before taking NOVO-VALSARTAN make sure your doctor knows about all the medications you are taking, including those not prescribed by your doctor. It may be necessary to change the dose, take other precautions, or perhaps stop one of the medicines. This applies to both prescription and non-prescription medicines.

PROPER USE OF THIS MEDICATION

If your doctor has prescribed NOVO-VALSARTAN for you following a heart attack, it is important to continue to take it even if you feel well, so that NOVO-VALSARTAN can help to reduce the chance of another heart attack occurring.

Patients who have high blood pressure often do not notice any signs or symptoms of this condition. So even though you are feeling well, your health may be getting worse. This makes it all the more important for you to continue your treatment program and to keep your appointments with your doctor.

Remember that this medicine does not cure your high blood pressure; it only may help to control it. Therefore, if you want to lower your blood pressure and keep it down, you must continue to take NOVO-VALSARTAN as directed.

Usual dose:

It is very important that you take this medicine exactly as your doctor tells you in order to get the best results and reduce the chance of side effects.

High blood pressure (hypertension)

The usual dosage for the treatment of high blood pressure is one 80 mg tablet once a day. In some cases, your doctor may increase the dose to 160 mg and then eventually to 320 mg or prescribe it together with another medicine (e.g., a diuretic).

Following a heart attack (myocardial infarction) Treatment is generally started as soon as 12 hours following the heart attack, usually at a low dose of 20 mg twice daily in order to minimise side effects including hypotension (low blood pressure). Your doctor may increase this dose gradually over several weeks to a maximum of 160 mg twice daily.

Failing heart (heart failure)

Treatment is generally started at a dose of 40 mg twice daily in order to minimize side effects including low blood pressure. Your doctor may increase this dose gradually over several weeks to a maximum of 160 mg twice daily.

Swallow NOVO-VALSARTAN tablets with a glass of water. You can take NOVO-VALSARTAN with or without food, but it should be taken the same way each day and at the same time.

Overdose:

In the event of overdosage, contact your doctor, hospital emergency department or regional Poison Control Centre Immediately.

If you have accidentally taken too many tablets of NOVO-VALSARTAN, seek medical assistance immediately.

Missed Dose:

Try to take your dose at the same time each day, preferably in the morning. However, if you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not take a double dose to make up for the forgotten tablet.

For management of a suspected drug overdose, contact your regional Poison Control Centre.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, NOVO-VALSARTAN may cause unwanted reactions, so-called side effects. Most patients do not experience side effects from Valsartan. Examples of occasional side effects include:

  • Dizziness
  • Light headedness
  • Muscle pain or muscle weakness
  • Unusual tiredness and/or weakness
  • Headache
  • Diarrhea
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

Doctor or pharmacist

Stop taking Drug and Call your Doctor or Pharmacist
Only if severeIn all cases
Common

Allergic reactions

Skin rash, skin eruption or other effect on the skin or eyes

√
Uncommon
Low Blood Pressure (hypotension) Fainting when the blood pressure is too low√
Allergic reactions Swelling of the lips, face or neck, accompanied by difficulty in breathing or speaking√
Kidney and Liver disorder Symptoms such as nausea, vomiting dark/brown urine√
Muscle tenderness or weakness generalized weakness (sign of rhabdomyolysis)√
Abdominal pain√

This is not a complete list of side effects. For any unexpected effects while taking NOVO-VALSARTAN, contact your doctor or pharmacist.

HOW TO STORE IT

Do not take NOVO-VALSARTAN past the expiry date shown on the pack.

How to store your tablets:

Protect from light, heat and humidity. Store between 15°C and 30°C.

Always remember

This medicine has been prescribed to you for your current medical problem only. Do not give it to other people.

Keep this medicine out of the reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

-------------------------------------------------------------------

$ Report online at

www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345

$ Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701D Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at

www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

Please consult your doctor or pharmacist with any questions or concerns you may have regarding your individual condition.

This document plus the full product monograph, prepared for health professionals can be found by contacting Teva Canada Limited at:

1-800-268-4127 ext. 5005 (English);

1-877-777-9117 (French)

or druginfo@tevacanada.com

Teva Canada Limited

30 Novopharm Court

Toronto, Ontario

Canada, M1B 2K9

Last revised: October 20, 2010

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02358433

Revision date stated in the text: October 20, 2010

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Novo-Valsartan

Rx or OTC
Prescription (Rx)?
DIN 02358433, 02358441, 02358468, 02358476
Schedule(s) PRESCRIPTION
Active ingredient(s) Valsartan
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA03 Valsartan
Company TEVA CANADA LIMITED
Current status Cancelled Pre Market
Current status date October 16, 2015
Strengths and forms
DIN Strength Dosage form(s) Current status
02358433 40 MG Tablet Cancelled Pre Market October 16, 2015
02358441 80 MG Tablet Cancelled Pre Market October 16, 2015
02358468 160 MG Tablet Cancelled Pre Market October 16, 2015
02358476 320 MG Tablet Cancelled Pre Market October 16, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.